- Country: Ecuador
- Summary: Oral Solid Gliclazide Acquisition (Extended Release) 30 Mg Dsscf
- ECT Ref No: 112038576
- Deadline: 06 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: USD 309034.14
- Notice Type: Tender
- Document Ref. No.: SIE-IESS-2024-00162
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Process Object: ACQUISITION OF GLICLAZIDE ORAL SOLID (EXTENDED RELEASE) 30 MG DSSCF
Purchase Type: Good
Description: ACQUISITION OF GLICLAZIDE ORAL SOLID (EXTENDED RELEASE) 30 MG DSSCF
Type of Contract: Electronic Reverse Auction -
Total Reference Budget ( Without VAT) : USD - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINOral Solid Gliclazide Acquisition (Extended Release) 30 Mg Dsscf - Ecuador Tender
The ECUADORIAN INSTITUTE OF SOCIAL SECURITY, a Government sector organization in Ecuador, has announced a new tender for Oral Solid Gliclazide Acquisition (Extended Release) 30 Mg Dsscf. This tender is published on EcuadorTenders under ECT Ref No: 112038576 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-06.
The estimated tender value is USD 309034.14, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
